A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
Clinical trial NCT05332366 · COMPLETED
Trial details
- NCT number
- NCT05332366
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2023-02-13
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.